Asian Oncol Nurs.  2019 Mar;19(1):47-54. 10.5388/aon.2019.19.1.47.

The Influence of Resilience on the Quality of Life of Patients with non-Hodgkin Lymphoma

• Shim SH
• Kim JH

• KMID: 2451721
• DOI: http://doi.org/10.5388/aon.2019.19.1.47

Abstract

PURPOSE
The purpose of this study was to investigate the resilience and quality of life (QoL) of patients with non-Hodgkin lymphoma (NHL) and the factors influencing QoL.
METHODS
A sample of 85 outpatients who had been diagnosed with NHL were included in a descriptive study. The instruments used were the Connor-Davidson Resilience Scale and Functional Assessment of Cancer Therapy-Lymphoma (FACT-Lym) version 4.
RESULTS
The mean resilience score of the patients was 73.11±15.81 out of 100. The total mean QoL score was 130.23±20.70 out of 168, the highest category was physical well-being with a mean item score of 21.80±5.03, the lowest was emotional well-being with a mean item score of 19.28±3.95. Resilience and QoL were positively correlated (r=.65, p<.001). Regression analysis revealed that the QoL of the patients was explained by resilience, gender, and Eastern Cooperative Oncology Group performance status. These variables explained 53% of the variance of QoL.
CONCLUSION
The results of this study confirmed the importance of resilience for QoL among patients with NHL and the relevant factors that affect QoL. This can be used as a basis for nursing interventions for NHL patients.

Keyword

Non-Hodgkin's Lymphoma; Resilience; Quality of life

MeSH Terms

Humans
Lymphoma, Non-Hodgkin*
Nursing
Outpatients
Quality of Life*

Reference

1. National Cancer Center (KR). Korea Central Cancer Registry. Annual report of cancer statistics in Korean 2014 [Internet]. Accessed September 28, 2018. Available from: http://ncc.re.kr/cancerStatsView.ncc?bbsnum=397&searchKey=total&searchValue=&pageNum=1.

2. The Blood of Lymphoma Study Group. The correct understanding of lymphoma. Seoul: Korean Medicine;2017.

3. The Korean Society of Hematology. Malignant lymphoma [Internet]. Accessed January 10, 2019. Available from: http://www.hematology.or.kr/sub07/hematodyscrasia06.pdf.

4. Kim JH. A study on the development and application of the nursing program for cancer patients undergoing chemotherapy [master's thesis]. Seoul: Hanyang Univ.;2003.

5. Asan Medical Center. Understanding lymphoma [Internet]. Accessed January 10, 2019. Available from: http://cancer.amc.seoul.kr/asan/depts/cancer/K/content.do?menuId=3636.

6. Park MS, Kim KS. Cancer survivors’ life experience. J Korean Oncol Nurs. 2008; 8:93–104.

7. Thompson CA, Yost KJ, Maurer MJ, Allmer C, Farooq U, Habermann TM, et al. Quality of life at diagnosis predicts overall survival in patients with aggressive lymphoma. Hematol Oncol. 2018; 36:749–756.

8. Gotay CC, Kawamoto CT, Bottomley A, Efficace F. The prognostic significance of patient-reported outcomes in cancer clinical trials. J Clin Oncol. J Clin Oncol. 2008; 26:1355–1363.

9. Sandler IN, Wolchik SA, Ayers TS. Resilience rather than recovery: a contextual framework on adaptation following bereavement. Death Stud. 2008; 32:59–73.

10. Choi UJ, Kim YS, Kang JS. Effect of uncertainty and resilience on stress for cancer patients. Korean J Stress Res. 2018; 26:250–256.

11. Jung SC. The relationship among resilience, stress and self care of cancer patients receiving chemotherapy [master's thesis]. Jinju: Gyeongsang National Univ.;2012.

12. Connor KM, Davidson JR. Development of a new resilience scale: the Connor-Davidson Resilience Scale (CD-RISC). Depress Anxiety. 2003; 18:76–82.

13. Webster K, Cella D. Quality of life in patients with low-grade non-Hodgkin’s lymphoma. Oncology (Williston Park). 1998; 12:697–714.

14. Kwak SY. The relationship between resilience and levels of family support, anxiety and depression in patients with hematologic malignancy [master's thesis]. Seoul: Ewha Womans Univ.;2012.

15. Kim JI, Byeon YS. A study on the factors affecting resilience in patients with colon cancer. Asian Oncol Nurs. 2013; 13:256–264.

16. Strauss B, Brix C, Fischer S, Leppert K, Füller J, Roehrig B, et al. The influence of resilience on fatigue in cancer patients undergoing radiation therapy (RT). J Cancer Res Clin Oncol. 2007; 133:511–518.

17. Lee EK. A study on factors affecting cancer patients. J Korean Acad Soc Nurs Educ. 2007; 13:52–58.

18. Choi KS, Park JA, Lee JH. The effect of symptom experience and resilience on quality of life in patients with colorectal cancers. Asian Oncol Nurs. 2012; 12:61–68.

19. Smith SK, Zimmerman S, Williams CS, Zebrack BJ. Health status and quality of life among non-Hodgkin lymphoma survivors. Cancer. 2009; 115:3312–3323.

20. Oh PJ. Predicting quality of life in people with cancer. J Nurs Acad Soc. 1997; 27:901–911.

21. Cappiello M, Cunningham RS, Knobf MT, Erdos D. Breast cancer survivors: information and support after treatment. Clin Nurs Res. 2007; 16:278–293.

22. Pettengell R, Donatti C, Hoskin P, Poynton C, Kettle PJ, Hancock B, et al. The impact of follicular lymphoma on health-related quality of life. Ann Oncol. 2008; 19:570–576.

23. Lee J, Kim M. Relationships among uncertainty, distress, and quality of life in lung cancer patients: mediating effect of resilience. J Muscle Joint Health. 2018; 25:148–156.

24. Park JA, Hong JY. Factors influencing quality of life in adult cancer patients: the Sixth Korea National Health and Nutrition Examination Survey (KNHANES VI-2), 2014. J Korea Acad Ind Coop Soc. 2017; 18:382–390.

25. Lee EJ, Yoon JH, Park D, Park D. Performance status and resilience in patients with colorectal cancer. Asian Oncol Nurs. 2013; 13:273–279.

26. Hong SK. Concept development of resilience - focusing on cancer patients -. J Korean Acad Soc Nurs Educ. 2009; 15:109–119.

27. Cella D, Webster K, Cashy J, Kutikova L, Burgess MF, Lin BK, et al. Development of a measure of health-related quality of life for non-Hodgkin’s lymphoma clinical research: the Functional Assessment of Cancer Therapy-Lymphoma (FACT-Lym). Blood. 2005; 106:750.

28. Yost KJ, Thompson CA, Eton DT, Allmer C, Ehlers SL, Habermann TM, et al. The Functional Assessment of Cancer Therapy - General (FACT-G) is valid for monitoring quality of life in patients with non-Hodgkin lymphoma. Leuk Lymphoma. 2013; 54:290–297.